IMPACT working groups

As per its Terms of Reference, IMPACT may establish Working Groups to address and advise IMPACT participants on specific issues relating to its goal and objectives, including the coordination of country focused initiatives. Working Groups will be lead by a Chairperson, selected by the General Meeting. The Chairperson must be a participant. For the beginning, 5 Working Groups have been established as outlined below.

Working Groups must ensure that participants and invited experts have the appropriate expertise. As long as this is ensured, Working Groups’ composition will aim at ensuring representation of the different stakeholders. The Planning Group and the IMPACT Secretariat will have to ensure that these principles are met.

Each Working Group will develop proposed work plans, report and submit proposals to the General Meeting through the Planning Group.

Communications Working Group

Communications Working Group

The infiltration and sale of counterfeit medical products in the legitimate supply chain can cause death and misery to thousands of patients around the world. Failure to act to prevent this criminal activity would be a fundamental breach of the trust that patients place in public health structures. Any effective solution must drive immediate change, be effective in the long term and receive the support and active engagement of all stakeholders involved in the medical products supply chain...

Legislative and Regulatory Infrastructure Working Group

Legislative and Regulatory Infrastructure Working Group

In most countries, national legislation is often not equipped to deal with the extremely serious health consequences of counterfeit medical products and penalties for counterfeiters are too light to act as deterrents. Stronger legislation clearly identifying counterfeiting medical products as a crime will help to empower police, customs officials and the judiciary to better fight this crime...

Regulatory Implementation Working Group

Regulatory Implementation Working Group

Counterfeit medical products pose a significant danger to public health in developing as well as developed countries. Counterfeits may be distributed through different distribution channels such as governmental health systems, hospitals, pharmacies, other legitimate or illegitimate distributors, as well as sold over the internet...

Enforcement Working Group

Enforcement Working Group

Today, nothing short of a global approach to inhibiting the flow of potentially deadly counterfeit medical products is required. Every country around the world suffers the same problems. The global trade in medicines and medical devices necessitates that countries actively work together and commit to reducing the international trade in counterfeit medical products...

Technology Working Group

Technology Working Group

There are many anti-counterfeit technologies available to manufacturers and brand owners, ranging from the very simple but effective to the highly sophisticated and extremely secure. The majority can be implemented on one or more of the packaging components, but some features can even be applied at the product level...

Events presentations/conclusions

IMPACT brochure

Upcoming events